Skip to main navigation
Aprea TherapeuticsAprea Therapeutics

    home

  • Home
  • about

  • our company
  • Our Science

  • our pipeline
  • Pipeline

  • our science
  • Contact

  • our clinical trials
  • IR Nav

  • investors & media
    • Overview
    • News & Events
    • Stock Information
    • Governance
    • Financials
    • Investor Resources

SEC Filing

SEC Filing Details

Document Details

Form
10-K/A
Filing Date
May 2, 2022
Document Date
Dec 31, 2021
Form Description
Amendment to a previously filed 10-K
Filing Group
Annual Filings
Company
Aprea Therapeutics
Issuer
Aprea Therapeutics, Inc.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.DEF - EX-101.DEF
EX-101.LAB - EX-101.LAB
EX-101.PRE - EX-101.PRE
XML - XBRL INSTANCE DOCUMENT

Shareholder Tools

USA

535 Boylston St.
Boston, MA 02116

USA

3805 Old Easton Road
Doylestown, PA 18902
 

CONTACT

info@aprea.com

© 2023 Aprea Therapeutics.

    home

  • Home
  • about

  • our company
  • Our Science

  • our pipeline
  • Pipeline

  • our science
  • Contact

  • our clinical trials
  • IR Nav

  • investors & media
    • Overview
    • News & Events
    • Stock Information
    • Governance
    • Financials
    • Investor Resources